Open AccessAnticholinergic Medication Burden in Parkinson’s Disease Outpatients
Author(s) -
Huma Nawaz,
Lana Sargent,
Helengrace Quilon,
Leslie J. Cloud,
Claudia Testa,
Jon D Snider,
Sarah K. Lageman,
Mark S. Baron,
Brian D. Berman,
Kristin Zimmerman,
Elvin Price,
Nitai D. Mukhopadhyay,
M. Barrett
Publication year - 2022
Publication title -
journal of parkinson's disease/journal of parkinson's disease (online)
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.747
H-Index - 45
eISSN - 1877-718X
pISSN - 1877-7171
DOI - 10.3233/jpd-212769
Subject(s) - anticholinergic , medicine , anticholinergic agents , antipsychotic , psychiatry , schizophrenia (object oriented programming)
Individuals with Parkinson's disease (PD) may be especially vulnerable to future cognitive decline from anticholinergic medications.